Trials / Completed
CompletedNCT03160053
Improving Keloids Using Targeted Ultraviolet-B Irradiation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- Johns Hopkins University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Treatment of keloids with targeted Ultraviolet-Beta (UVB) radiation will improve the clinical appearance and induration of lesions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NB-UVB | NB-UVB has an emission spectrum in the ultraviolet B range of 290-320 nm. The system consists of a light source, a spot handpiece, and a light guide that connects the handpiece to the light source. The light source has a Start/Stop switch for light beam activation. Activation can also be controlled remotely with a foot switch. The light source has a timer and an output level control to adjust the intensity of the ultraviolet light. This will be calibrated using a manufacturer-provided UV meter prior to every treatment to ensure accurate doses of ultraviolet light. |
Timeline
- Start date
- 2015-06-23
- Primary completion
- 2015-11-20
- Completion
- 2018-06-15
- First posted
- 2017-05-19
- Last updated
- 2018-06-19
Source: ClinicalTrials.gov record NCT03160053. Inclusion in this directory is not an endorsement.